Investigating the relationship between vitamin D and cancer requires dosing
the bio-available non-hydroxylated vitamin D storage in cancer tissues. . CYP2R1 is the hydroxylase involved in the conversion of vitamin D into 25(OH)D. In the classical vitamin D endocrine system,activation of vitamin D into 1,25(OH)2D requires two successive hydroxylation steps. The first one is catalyzed by CYP2R1 in the liver and the second one by CYP27B1 in the kidneys. Then, 1,25D is released in the blood circulation and behaves as an endocrine hormone. The conversion of 25(OH)Dinto the active hormone 1,25(OH)2D by CYP27B1 is under stringent control. However, the first hydroxylation step catalyzed in the liver by CYP2R1 is constitutive and is not believed to be subjected to tight regulation. This has two important consequences: i) the regulation of liver CYP2R1 has retained little attention, and ii) circulating non-hydroxylated vitamin D is rapidly metabolized by liver CYP2R1. Therefore 
